V. Serre

Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence.

D. Drucker, B. Thorens, S. Efrat, 1998, Endocrinology.

Exendin-(9-39) Is an Inverse Agonist of the Murine Glucagon-Like Peptide-1 Receptor: Implications for Basal Intracellular Cyclic Adenosine 3',5'-Monophosphate Levels and β-Cell Glucose Competence* *This work was supported by Grant 31-46958.96 from the Swiss National Science Foundation (to B.T.).

D. Drucker, B. Thorens, S. Efrat, 1998, Endocrinology.

Loss of α1 connexin does not alter the prenatal differentiation of pancreatic β cells and leads to the identification of another islet cell connexin

A. Charollais, P. Meda, D. Bosco, 1999 .

Loss of alpha 1 connexin does not alter the prenatal differentiation of pancreatic beta cells and leads to the identification of another islet cell connexin.

A. Charollais, P. Meda, D. Bosco, 1999, Developmental genetics.

Process type is the key driver of the fate of organic micropollutants during industrial scale treatment of organic wastes.

D. Patureau, M. Bourdat-Deschamps, N. Sertillanges, 2020, The Science of the total environment.

Effects of cysteine modification on the activity of the cGMP-gated channel from retinal rods

N. Bennett, V. Serre, M. Ildefonse, 1995, The Journal of Membrane Biology.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.